|
 |
|
Listed Company Information
|
Shareholding Disclosures
|
| Latest Listed Company Information | Your attention is drawn to this disclaimer. |
| Sort By Time | Code | Name | |||
|---|---|---|---|
| Release Time | Code | Stock Name | Document (Hide Headline) |
| 15/04/2026 12:21 | 00905 | WALNUT CAP |
Announcements and Notices - (Net Asset Value) NET ASSET VALUE (81KB, PDF) |
| 15/04/2026 12:16 | 01333 | BRETON |
Announcements and Notices VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY THE DIRECTOR AND CONTROLLING SHAREHOLDER (151KB, PDF) |
| 15/04/2026 12:06 | 00178 | SA SA INT'L |
Announcements and Notices - (Profit Warning) Positive Profit Alert (83KB, PDF) |
| 15/04/2026 12:01 | 02017 | CHANHIGH |
Announcements and Notices - (Change in Directors or of Important Executive Functions or Resposnibilities) SUPPLEMENTARY ANNOUNCEMENT CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND BOARD COMMITTEE MEMBERS (211KB, PDF) |
| 15/04/2026 12:01 | 01044 | HENGAN INT'L |
Announcements and Notices - (Change in Directors or of Important Executive Functions or Resposnibilities) PROPOSED RE-DESIGNATION OF DIRECTOR (94KB, PDF) |
| 15/04/2026 12:01 | 01044 | HENGAN INT'L |
Announcements and Notices - (Notice of AGM) NOTICE OF ANNUAL GENERAL MEETING (107KB, PDF) |
| 15/04/2026 12:01 | 09963 | TRANSTECH |
Announcements and Notices - (Change in Directors or of Important Executive Functions or Resposnibilities) CHANGE OF AUTHORISED REPRESENTATIVE (300KB, PDF) |
| 15/04/2026 12:01 | 00460 | SIHUAN PHARM |
Announcements and Notices VOLUNTARY ANNOUNCEMENT- APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR NEW INDICATION OF ANAPRAZOLE SODIUM (468KB, PDF) |
| 15/04/2026 12:00 | 00178 | SA SA INT'L |
Announcements and Notices Unaudited Sales Update for the Fourth Quarter ended 31 March 2026 (98KB, PDF) |
| 15/04/2026 11:32 | 00390 | CHINA RAILWAY |
Next Day Disclosure Returns - (Share Buyback) Next Day Disclosure Return (89KB, PDF) |
| 15/04/2026 11:09 | 03836 | HARMONY AUTO |
Monthly Returns MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026 (REVISED) (65KB, PDF) |
| 15/04/2026 11:08 | 01044 | HENGAN INT'L |
Financial Statements Climate-related Financial Disclosures (TCFD) Report 2025 (1660KB, PDF) |
| 15/04/2026 11:06 | 03836 | HARMONY AUTO |
Monthly Returns MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025 (REVISED) (67KB, PDF) |
| 15/04/2026 11:06 | 01044 | HENGAN INT'L |
Financial Statements Environmental, Social and Governance Report 2025 (8546KB, PDF) |
| 15/04/2026 11:01 | 01044 | HENGAN INT'L |
Circulars - (Re-election or Appointment of Director subject to Shareholders’ Approval/Explanatory Statement for Repurchase of Shares/General Mandate/Other) Circular dated 15 April 2026 regarding (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) RE-ELECTION OF RETIRING DIRECTORS AND (3) NOTICE OF AGM (253KB, PDF) |
| 15/04/2026 10:54 | 01044 | HENGAN INT'L |
Financial Statements - (Annual Report) ANNUAL REPORT 2025 (15588KB, PDF) |
| 15/04/2026 08:38 | 03668 | YANCOAL AUS |
Announcements and Notices - (Resumption) EXCHANGE NOTICE - RESUMPTION OF TRADING (1KB, HTM) |
| 15/04/2026 08:38 | 00784 | LING YUI |
Announcements and Notices - (Resumption) EXCHANGE NOTICE - RESUMPTION OF TRADING (1KB, HTM) |
| 15/04/2026 08:15 | 02105 | LAEKNA-B |
Announcements and Notices INSIDE INFORMATION POSITIVE TOPLINE RESULTS PHASE III CLINICAL TRIAL (AFFIRM-205) OF LAE002 (AFURESERTIB) MET PRIMARY ENDPOINT OF PFS DEMONSTRATED HIGHLY STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL BENEFITS IN PATIENTS WITH PIK3CA/AKT1/PTEN ALTERATIONS AND HR+/HER2- LA/mBC (60KB, PDF) |
| 15/04/2026 08:00 | 09929 | SEM HLDGS |
Announcements and Notices - (Change in Shareholding) VOLUNTARY ANNOUNCEMENT DISPOSALS OF SHARES BY CONTROLLING SHAREHOLDER (81KB, PDF) |
Pursuant to the Codes on Takeovers and Mergers and Share Repurchases ("Takeovers Codes"), a copy of each document to be displayed under Note 1 to Rule 8 of the Takeovers Codes must be provided by the issuer of the offer document or offeree board circular, as appropriate, to Securities and Futures Commission ("SFC") for display on the SFC's website. To access these documents on display, you can either click this link http://www.sfc.hk/dod/jsp/EN/DoDmain.jsp or click the [View Documents on Display] button next to the subject title of the offer document or offeree board circular.
Some of the files are prepared in the portable document format and viewing them require Adobe(R) Acrobat(R) Reader which can be downloaded at http://www.adobe.com/products/acrobat/readstep2.html